Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

False Positive Urine Drug Screens in Patients Receiving Oral Naltrexone

Plant, Elizabeth MD, CCFP1,2,3; Yang, Lufang PhD, FCACB4,6; Hering, Ramm MD, MSc, CCFP, CCFP (Addiction Medicine) Dip. PH, Dip. ABAM, CCSAM, FASAM1,2,3; Nerenberg, Lucila MD, FRCPC, Dip. ABAM, CCSAM, FASAM2,3,5

Canadian Journal of Addiction: June 2019 - Volume 10 - Issue 2 - p 25–26
doi: 10.1097/CXA.0000000000000051
LETTER TO THE EDITOR
Buy

1British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada

2Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada

3Island Health, Victoria, British Columbia, Canada

4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

5Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada

6Laboratory Medicine, Pathology and Medical Genetics, Island Health, Victoria, British Columbia, Canada

Corresponding Author: Lucila Nerenberg, MD, FRCPC, Dip. ABAM, CCSAM, FASAM, Clinical Assistant Professor, Department of Psychiatry, University of British Columbia, 1125 Pembroke St, Victoria, BC, Canada V8T 1J3. Tel: +1 250 213 4439, e-mail: lucila.nerenberg@viha.ca

The authors report no conflicts of interest.

© 2019 by Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website